| pubmed-article:17140168 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0035096 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0003364 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C1524003 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:17140168 | lifeskim:mentions | umls-concept:C2699424 | lld:lifeskim |
| pubmed-article:17140168 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17140168 | pubmed:dateCreated | 2006-12-4 | lld:pubmed |
| pubmed-article:17140168 | pubmed:abstractText | The burden of diabetes mellitus type 2 (DM2) is increasing worldwide. The combination of DM2 and hypertension (HT) is frequently encountered. Concurrent use of drugs blocking the renin angiotensin system (angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB)) and metformin have become frequent in this group of patients. That combination can become life-threatening under certain circumstances. | lld:pubmed |
| pubmed-article:17140168 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17140168 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17140168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140168 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17140168 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17140168 | pubmed:issn | 0301-0430 | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:OzFF | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:KroghAA | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:HeldalKK | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:Gudmundsdotti... | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:RudbergNN | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:AksnesHH | lld:pubmed |
| pubmed-article:17140168 | pubmed:author | pubmed-author:FroyshovSS | lld:pubmed |
| pubmed-article:17140168 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17140168 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:17140168 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17140168 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17140168 | pubmed:pagination | 380-5 | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:meshHeading | pubmed-meshheading:17140168... | lld:pubmed |
| pubmed-article:17140168 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17140168 | pubmed:articleTitle | Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern? | lld:pubmed |
| pubmed-article:17140168 | pubmed:affiliation | Department of Nephrology, Ulleval University Hospital, Oslo, Norway. helga.gudmundsdottir@ulleval.no | lld:pubmed |
| pubmed-article:17140168 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17140168 | pubmed:publicationType | Case Reports | lld:pubmed |
